AR011447A1 - Procedimiento para preparar un derivado de tiazolidindiona substituido y compuesto intermediario - Google Patents

Procedimiento para preparar un derivado de tiazolidindiona substituido y compuesto intermediario

Info

Publication number
AR011447A1
AR011447A1 ARP980100684A ARP980100684A AR011447A1 AR 011447 A1 AR011447 A1 AR 011447A1 AR P980100684 A ARP980100684 A AR P980100684A AR P980100684 A ARP980100684 A AR P980100684A AR 011447 A1 AR011447 A1 AR 011447A1
Authority
AR
Argentina
Prior art keywords
formula
preparing
procedure
pharmaceutically acceptable
substituted
Prior art date
Application number
ARP980100684A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268725&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR011447(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9703338.5A external-priority patent/GB9703338D0/en
Priority claimed from GBGB9703334.4A external-priority patent/GB9703334D0/en
Priority claimed from GBGB9703310.4A external-priority patent/GB9703310D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR011447A1 publication Critical patent/AR011447A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento para preparar un derivado de tiazolidindiona substituido de formula (I) o una de sus formas tautomeras o una de sus salesfarmacéuticamente aceptables po uno de sus solvatos farmacéuticamente aceptables, en la que: Jrepre senta O o S; T representa un grupo arilosubstituídos o no y T1 es O o S; comprendiendo dicho procedimiento, reducir un compuesto de formula (II); o una de sus formas tautomeras o una de sus sales ouno de sus solvatos, en la que T y T1 soncomo se ha n definido con relacion a la formula (I), con un agente reductor de hidruro complejo o una fuente de unagente reductor de hidruro complejo; y a continuacion, si se requiere, preparar una sal farmacéuticamente aceptable o un solvatofarmacéuticament e aceptabledel compuesto de formula (I) o una de sus formas tautomeras, compuesto que tiene la formula (III); o una de sus formas tautomeras, o de sus sales, o desus solvatos, en la que J y T son tal como se definen en lo queantecede en relacio n a la formula (I).
ARP980100684A 1997-02-18 1998-02-16 Procedimiento para preparar un derivado de tiazolidindiona substituido y compuesto intermediario AR011447A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703338.5A GB9703338D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703334.4A GB9703334D0 (en) 1997-02-18 1997-02-18 Novel compounds
GBGB9703310.4A GB9703310D0 (en) 1997-02-18 1997-02-18 Novel process

Publications (1)

Publication Number Publication Date
AR011447A1 true AR011447A1 (es) 2000-08-16

Family

ID=27268725

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100684A AR011447A1 (es) 1997-02-18 1998-02-16 Procedimiento para preparar un derivado de tiazolidindiona substituido y compuesto intermediario

Country Status (29)

Country Link
EP (2) EP1770092A1 (es)
JP (2) JP2001514619A (es)
KR (1) KR20000071138A (es)
CN (1) CN1252065A (es)
AP (1) AP1359A (es)
AR (1) AR011447A1 (es)
AU (1) AU6622398A (es)
BG (1) BG64311B1 (es)
BR (1) BR9807395A (es)
CA (1) CA2281695C (es)
CZ (1) CZ296272B6 (es)
DZ (1) DZ2430A1 (es)
EA (1) EA199900754A1 (es)
HU (1) HUP0001459A3 (es)
ID (1) ID22222A (es)
IL (1) IL131392A (es)
IN (1) IN188379B (es)
MA (1) MA24475A1 (es)
MY (1) MY129475A (es)
NO (2) NO313290B1 (es)
NZ (1) NZ337179A (es)
OA (1) OA11148A (es)
PE (1) PE71899A1 (es)
PL (1) PL195482B1 (es)
SK (2) SK287512B6 (es)
TR (1) TR199902019T2 (es)
TW (1) TWI222446B (es)
UY (1) UY24886A1 (es)
WO (1) WO1998037073A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
GB9723295D0 (en) 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
NZ515168A (en) * 1999-04-23 2004-02-27 Smithkline Beecham Plc Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
FR2820741A1 (fr) * 2001-02-14 2002-08-16 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
US7767701B2 (en) 2002-11-22 2010-08-03 Glaxosmithkline Llc Chemical compounds
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
EP1745043A1 (en) * 2004-05-12 2007-01-24 Medichem S.A. Process for the preparation of rosiglitazone
CZ297266B6 (cs) * 2004-09-10 2006-10-11 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
JPH0377875A (ja) * 1989-08-18 1991-04-03 Kaken Pharmaceut Co Ltd チアゾリジン‐2,4‐ジオン誘導体およびその製造法
EP0839812A1 (en) * 1990-04-27 1998-05-06 Sankyo Company Limited Preparation of benzylthiazolidine derivatives
US5585495A (en) * 1991-12-20 1996-12-17 The Upjohn Company Reduction method for substituted 5-methylene-thiazolidinediones
JPH08157473A (ja) * 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
JPH08217717A (ja) * 1995-02-10 1996-08-27 Sumitomo Chem Co Ltd 環状ケトン系化合物、その製造法およびそれを有効成分とするゴキブリ誘引剤
NZ308228A (en) * 1995-05-31 1999-11-29 Sumitomo Pharma Substituted 1,8-naphthyridine derivatives

Also Published As

Publication number Publication date
OA11148A (en) 2003-04-16
MY129475A (en) 2007-04-30
EA199900754A1 (ru) 2000-04-24
SK285979B6 (sk) 2007-12-06
DZ2430A1 (fr) 2003-01-11
CZ292499A3 (cs) 2000-02-16
CZ296272B6 (cs) 2006-02-15
CA2281695A1 (en) 1998-08-27
EP0970063A1 (en) 2000-01-12
BR9807395A (pt) 2000-03-14
ID22222A (id) 1999-09-16
BG103735A (en) 2000-06-30
AP1359A (en) 2004-12-02
AP9901626A0 (en) 1999-09-30
PL335163A1 (en) 2000-04-10
CN1252065A (zh) 2000-05-03
MA24475A1 (fr) 1998-10-01
HUP0001459A2 (hu) 2000-10-28
WO1998037073A1 (en) 1998-08-27
PL195482B1 (pl) 2007-09-28
SK112099A3 (en) 2000-05-16
NO20023937D0 (no) 2002-08-19
JP2009149616A (ja) 2009-07-09
HUP0001459A3 (en) 2002-11-28
UY24886A1 (es) 2001-08-27
NO993949L (no) 1999-09-07
NO313290B1 (no) 2002-09-09
CA2281695C (en) 2006-12-12
IN188379B (es) 2002-09-14
NZ337179A (en) 2001-07-27
TR199902019T2 (xx) 1999-12-21
IL131392A (en) 2005-07-25
TWI222446B (en) 2004-10-21
PE71899A1 (es) 1999-09-15
NO993949D0 (no) 1999-08-17
SK287512B6 (sk) 2010-12-07
JP2001514619A (ja) 2001-09-11
NO20023937L (no) 1999-09-07
BG64311B1 (bg) 2004-09-30
AU6622398A (en) 1998-09-09
KR20000071138A (ko) 2000-11-25
EP1770092A1 (en) 2007-04-04
IL131392A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
NO952151D0 (no) Injiserbare, taxanderivat-baserte preparater
AR011447A1 (es) Procedimiento para preparar un derivado de tiazolidindiona substituido y compuesto intermediario
ES2167326T3 (es) N-acetilglucosaminil-transferasa, gen que la codifica, vectores y huespedes transformados correspondientes y procedimientos para su produccion.
ECSP082712A (es) Procedimiento i para preparar derivados de tiazolidindiona
AR006390A1 (es) Derivados de lactama
AR031031A1 (es) Composicion pesticida
EA200200316A1 (ru) Соединения для лечения ишемии
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
MX9205462A (es) Proceso y equipo para teñido de cabello
AR005752A1 (es) Composicion para limpiar superficies de vidrios
ES2079576T3 (es) Derivados piranicos biciclicos y su uso como inhibidores de 5-lipoxigenasa.
MX247325B (es) Procedimiento para la obtencion de derivados de triazolintiona.
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
ES2054626T3 (es) Derivados de 2-azetidinona sustituidos en las posiciones 3,4 y procedimientos para su preparacion.
ES2106936T5 (es) Derivados de carbazolona y procedimientos para su preparacion.
SE7706469L (sv) Forfarande for hydrering av vitaminanaloger
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
IT7926372A0 (it) Dispersioni acquose stabilizzate di coloranti.
NZ505200A (en) Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
ATE325112T1 (de) N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate
ECSP982415A (es) Nuevo procedimiento
EA199700395A1 (ru) Способ получения ингибиторов протеазы вируса иммунодефицита человека
ES530579A0 (es) Un procedimiento para preparar una composicion detergente blanqueante que tiene como agente de blanqueo un compuesto poroxigenado.
IT1096161B (it) Indolo-diidroindolo dimerico,utile quale agente anti-tumorale
ES420538A1 (es) Procedimiento para la obtencion de 1,2,4-triazina-1,4-di-n-oxidos.

Legal Events

Date Code Title Description
FG Grant, registration